Search

everythinglearnresearchcommunity

for

Search:↓

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

More research is needed on CCCA in children, especially Black and Asian adolescents.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

CCCA can affect both genders and all ages, and it has a genetic component.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Younger age, longer disease duration, frequent wig use, and lower education levels worsen quality of life in CCCA patients.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

DNA analysis can help tailor alopecia treatment.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.